학술논문
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy.
Document Type
Article
Author
Source
ACS Omega; 9/15/2020, Vol. 5 Issue 36, p22759-22771, 13p
Subject
Language
ISSN
24701343